Peroxisome Problems in Alzheimer's Disease Remain an Unsettled Question
Peroxisomes help regulate lipid processing and oxidative balance, and their function appears to decline with age. Abnormal peroxisome activity has been linked to Alzheimer's disease, but the evidence does not yet establish a causal role. The authors suggest that restoring more youthful peroxisome function could help clarify the connection.
Peroxisomes are single-membrane organelles found across eukaryotic cells. They house oxidative and lipid-processing enzymes and participate in very-long-chain fatty acid breakdown, branched-chain fatty acid degradation, bile acid production, plasmalogen synthesis, and local reactive oxygen species balance.
In the brain, these functions intersect with membrane lipid makeup, myelin integrity, synaptic plasticity, and redox control. Peroxisomes also coordinate metabolically with the endoplasmic reticulum, mitochondria, lipid droplets, and lysosomes. Alzheimer’s tissue and animal models show lower plasmalogens and peroxisomal enzyme activity, plus more lipid peroxidation and oxidative stress, but causality remains unresolved.
Because peroxisome biology is still an unsettled causal question in Alzheimer’s disease, near-term societal impact may be modest and mostly indirect. Patients, families, and caregivers could be affected if clearer mechanisms lead to better biomarkers or trial designs; researchers and drug developers may gain a testable framework. However, without longitudinal human evidence and validated target-engagement markers, claims about restoring youthful peroxisome function could outpace the science and create unrealistic expectations.